Tevogen Bio (TVGN) EBITDA (2021 - 2026)
Tevogen Bio (TVGN) EBITDA from Apr 30, 2021 to Mar 31, 2026. The TTM Tevogen Bio (TVGN) EBITDA is -$21M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Tevogen Bio (TVGN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -38.67% |
| All Time TTM | +604.64% |
Annual EBITDA change of Tevogen Bio (TVGN)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$5.37M | -79.31% |
| 2025 | -$26M | -51.40% |
| 2024 | -$53M | +515.21% |
| 2023 | -$8.68M | -296.83% |
| 2022 | $4.41M | -22150.00% |
| 2021 | -$20K | N/A |